Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

View:
Post by LouisW on Nov 15, 2023 12:17pm

Soleus

Based on the latest information, Soleus sold all the shares they had in Q3.

https://fintel.io/so/ca/th/soleus-capital-management-l-p

However, when I look into the insider section of Stockhouse, Soleus acquired lots of shares in Q3 and ended up the largest shareholder and insider.

I am confused...the information I found is paradoxical. BTW, Morgan Stanley haven't disclosed the details. And Taimed sold a lot in Q3.
Comment by palinc2000 on Nov 15, 2023 1:08pm
They are still listed on Sedi.ca as insiders with more than 10% of outstanding shares so there appears to be a mistake on Fintel  
Comment by palinc2000 on Nov 15, 2023 1:10pm
Insider number SMUSUME001  
Comment by SPCEO1 on Nov 15, 2023 1:11pm
Bloomberg has Soleus acquiring over 9 million new shares since 6/30, including the 2.5 million we know about in the offering. They now own 24% of THTX's stock if Bloomberg has it correct. So, IQ and Soleus control almost 50% of the stock. Let's hope they treat the rest of us well over time. If it is true Soleus owns that much, it indicates theya re still quite confident about TH-1902 ...more  
Comment by Trogarzon on Nov 15, 2023 1:21pm
Maybe they did a cross for tax pupose like like year also.
Comment by Lee430 on Nov 15, 2023 1:58pm
Wasn't there a 5 million share cross after hours recently that Could account for the additional shares Solis is required?
Comment by Lee430 on Nov 15, 2023 2:02pm
Soleus has acquired...
Comment by Trogarzon on Nov 15, 2023 2:59pm
Yes, that's it.  IQ has 20% and Soleus 10%.  
Comment by LouisW on Nov 15, 2023 6:53pm
Fintel Soleus
Comment by LouisW on Nov 15, 2023 6:55pm
Based on the fintel's information, both Soleus and Morgan Stanley sold all of their shares in Q3. But I don't know if the information listed on Fintel is reliable since Soleus related information is paradoxical.
Comment by palinc2000 on Nov 15, 2023 7:08pm
IF that were accurate they would not have been deemed to be INsiders with a mere purchase of 2.5 million shares on Oct 31    
Comment by scarlet1967 on Nov 16, 2023 4:26pm
" Don't put all your eggs in one basket". To me it seems the company is taking risky approach trying to have fewer/bigger investors who will have too much influence over their business. If Soleus, Morgan Stanley and now IQ own almost or more than "50 percent" of THTX then they will have too much control of the company.  It seems like smaller shareholders ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities